1-184795152-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_052966.4(NIBAN1):c.2612C>T(p.Ala871Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,614,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A871S) has been classified as Uncertain significance.
Frequency
Consequence
NM_052966.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NIBAN1 | NM_052966.4 | c.2612C>T | p.Ala871Val | missense_variant | 14/14 | ENST00000367511.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NIBAN1 | ENST00000367511.4 | c.2612C>T | p.Ala871Val | missense_variant | 14/14 | 1 | NM_052966.4 | P1 | |
NIBAN1 | ENST00000417056.5 | c.260+2927C>T | intron_variant | 3 | |||||
NIBAN1 | ENST00000487074.5 | n.2084C>T | non_coding_transcript_exon_variant | 9/9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152262Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251356Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135844
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461798Hom.: 0 Cov.: 33 AF XY: 0.0000413 AC XY: 30AN XY: 727206
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152380Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74522
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 04, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at